Surgical aspects of the diabetic foot

Journal of Bone and Joint Surgery - Series B

Volumn 91, Issue 1, 2009, Pages 1-7

  Robinson, A H N ^a,b   Pasapula, C ^a,b   Brodsky, J W ^a,c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANKLE FRACTURE; ANTIBIOTIC THERAPY; ARTHRODESIS; ARTHROPLASTY; BLOOD GLUCOSE MONITORING; BONE RESECTION; BONE SCINTISCANNING; CAST APPLICATION; DEBRIDEMENT; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; DIABETIC PATIENT; FOOT AMPUTATION; FOOT CARE; FOOT FRACTURE; FRACTURE FIXATION; HUMAN; IMMOBILIZATION; INCIDENCE; LEG LENGTHENING; NEUROLOGIC EXAMINATION; NEUROPATHIC JOINT DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOTOMY; PRIORITY JOURNAL; REVIEW; SOFT TISSUE INFECTION; VASCULAR SURGERY;

ANKLE INJURIES; ARTERIOSCLEROSIS; ARTHROPATHY, NEUROGENIC; DIABETIC FOOT; FEMALE; FRACTURE FIXATION, INTERNAL; FRACTURES, BONE; GREAT BRITAIN; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WOUND HEALING;

EID: 58149392718     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.91B1.21196     Document Type: Review

References (63)

1. Wild S, Roglic G, Green A, Cicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
2. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 1995;16:388-94.
3. No authors listed. Diabetes key facts: http://www.diabetes.nhs.uk/ downloads/YHPHO (date last accessed October 2007).
4. Newrick P. International consensus on the diabetic foot. BMJ 2000;321:642.
5. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care 2004;27:901-7.
6. Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med 1992;9:349-53.
7. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalenece of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complication study. Diabetologia 1996;39:1377-84.
8. Rathur RM, Boulton HAM. Recent advances in the diagnosis and management of diabetic neuropathy. J Bone Joint Surg [Br] 2005;87-B:1605-10.
9. Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJM. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabetic Medicine 2002;10:870-3.
10. Melton LJ, Macken KM, Palumbo PJ, Elveback LR. Instance and prevalence of clinical peripheral vascular disease in a population based cohort of diabetic patients. Diabetes Care 1980;3:650-4.
11. Boulton A. A pathway to ulceration aetiopathogenesis. The foot in diabetes. Second edition. 1994:37-48.
12. Meijer JG, Smit AJ, Lefrandt JD, et al. Back to basics in diagnosing diabetic polyneuropathy with the tuning fork. Diabetic Care 2005;28:2201-5.
13. Gin H, Rigalleau V, Baillet L, Rabemanantsoa C. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication. Diabetes Metab 2002;28:457-61.
14. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information. Diabetic Care 2006;29:1202-7.
15. Klenerman L. Screening for patients at risk of diabetic foot ulceration in a general diabetic outpatient clinic. Diabet Med 1996;13:561-3.
16. Pham H, Armstrong DG, Harvey C, et al. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicentre trial. Diabetes Care 2000;23:606-11.
17. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting: a prospective evaluation of single screening criteria. Diabetes Care 1992;15:1386-9.
18. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 1985;71:516-22.
19. Apelqvist J, Castenfors J, Larsson J, Stenstrom A, Agardh CD. Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 1989;6:373-8.
20. Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care 1999;22:147-51.
21. Verhelst R, Brunea M, Nicolas A-L, et al. Popliteal-to-distal bypass grafts for limb salvage. Ann Vasc Surg 1997;11:505-9.
22. Yuh WT, Corson JD, Baraniewski HM, et al. Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging. AJR Am J Roentgenol 1989;152:795-800.
23. Park HM, Wheat LJ, Siddiqui AR, et al. Scintigraphic evaluation of diabetic osteomyelitis: concise communication. J Nucl Med 1982;23:569-73.
24. Kraft E, Spyropoulos E, Finby N. Neurogenic disorders of the foot in diabetes mellitus. Am J Roentgenol Radium Ther Nucl Med 1975;124:17-24.
25. Jay PR, Michelson JD, Mizel MS, Magid D, Le T. Efficacy of three-phase bone scans in evaluation diabetic foot ulcers. Foot Ankle Int 1999;20:347-55.
26. Gold RH, Tong DJF, Crim JR, Seeger LL. Imaging the diabetic foot. Skeletal Radiol 1995;24:563-71.
27. Larcos G, Brown ML, Sutton RT. Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111 in-leukocyte scintigraphy. AJR Am J Roentgenol 1991;157:527-31.
28. Crerand S, Dolan M, Laing P, et al. Diagnosis of osteomyelitis in neuropathic foot ulcers. J Bone Joint Surg [Br] 1996;78-B:51-5.
29. Schauwecker DS, Park HM, Burt RW, Mock BH, Wellman HN. Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease. J Nucl Med 1988;29:1651-5.
30. Moore TE, Yuh WT, Kathol MH, el-Khoury GY, Corson JD. Abnormalities of the foot in patients with diabetes mellitus: findings on MR imaging. AJR Am J Roentgenol 1991;157:813-16.
31. Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999;22:1428-31.
32. Brand PW. Repetitive stress in the development of diabetic foot ulcers. In: Levin ME, Davidson JK, eds. The diabetic foot. Fourth edition. Mosby, St. Louis, Missouri, 1988:83-90.
33. Manley MT, Darby T. Repetitive mechanical stress and denervation in plantar ulcer pathogenesis in rats. Arch Phys Med Rehabil 1980;61:171-7.
34. Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers: a randomized clinical trial. J Bone Joint Surg [Am] 2003;85-A:1436-45.
35. Wagner F. Classification and treatment programme for diabetic, neuropathic and dysvascular foot problems. Inst Course Lect 1977;122:62.
36. Brodsky JW. Outpatient diagnosis and management of the diabetic foot. Inst Course Lect 1979;28:143-65.
37. Armstrong DG, Stacpoole-Shea S, Nguyen H, Harkless LB. Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg [Am] 1999;81-A:535-8.
38. Maluf S, Mueller MJ, Strube MJ, Engsberg JR, Johnson JE. Tendon Achilles lengthening for the treatment of neuropathic ulcers causes a temporary reduction forefoot pressure associated with changes in plantar flexon power rather than ankle motion during gait. J Biomech 2004;37:897-906.
39. Mueller MJ, Diamond JE, Sinacore DR, et al. Total contact casting in treatment of diabetic plantar ulcers: controlled clinical trial. Diabetes Care 1989;12:384-8.
40. Myerson M, Papa J, Eaton K, Wilson K. The total-contact cast for management of neuropathic plantar ulceration of the foot. J Bone Joint Surg [Am] 1992;74-A:261-9.
41. Armstrong DG, Lavery LA, Wu S, Boulton AJ. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 2005;28:551-4.
42. Nabuurs-Franssen MH, Sleegers R, Huijberts MSP, et al. Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 2005;28:243-7.
43. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 1996;19:607-12.
44. Armstrong DG, Nguyen HC, Lavery LA. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001;24:1019-22.
45. Trepman E, Pinzur MS, Shields NN. Application of the total contact case. Foot Ankle Int 2005;26:108-12.
46. Saltzman CL, Zimmerman MB, Holdsworth RL, et al. Effect of initial weight-bearing in a total contact cast on healing of diabetic foot ulcers. J Bone Joint Surg [Am] 2004;86-A:2714-19.
47. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-3.
48. Lavery LA, Armstrong DG, Peters EJ, Lipsky BA. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care 2007;30:270-4.
49. Shone A, Burnside J, Chipchase S, Game F, Jeffcoate W. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care 2006;29:945.
50. Crandall RC, Wagner FW Jr. Partial and total calcanectomy: a review of thirty-one consecutive cases over a ten-year period. J Bone Joint Surg [Am] 1981;63-A:152-5.
51. Brodsky JW. The diabetic foot. In: Coughlin MJ, Mann RA, Saltzman CL eds. Surgery of the foot and ankle. Philadelphia: Mosby Elsevier, 2007:1333.
52. Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthroplasty assocated with the peripheral bone mineral density. J Bone Joint Surg [Br]v2004;86-B:378-83.
53. Johnson JE. Operative treatment of neuropathic arthropathy of the foot and ankle. J Bone Joint Surg [Am] 1998;80-A:1700-9.
54. Brodsky JW. Patterns of breakdown in the Charcot tarsus of diabetics and relation to treatment. Foot and Ankle 1986;5:353.
55. Armstrong DG, Lavery LA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg [Am] 1998;80-A:365-9.
56. Brodsky JW, Rouse AM. Exostectomy for symptomatic bony prominences in diabetic charcot feet. Clin Orthop 1993;296:21-6.
57. Schwarz RJ, Macdonald MR, van der Pas M. Result of arthrodesis in neuropathic feet. J Bone Joint Surg [Br] 2006;88-B:747-50.
58. McCormack RG, Leith JM. Ankle fractures in diabetics: complications of surgical management. J Bone Joint Surg [Br] 1998;80-B:689-92.
59. Flynn JM, Rodriguez-del Rio F, Piza PA. Closed ankle fractures in the diabetic patient. Foot Ankle Int 2000;21:311-19.
60. Bibbo C, Lin SS, Beam HA, Behrens FF. Complications of ankle fractures in diabetic patients. Orthop Clin North Am 2001;32:113-33.
61. Jones JB, Maiers-Yelden KA, Marsh JL, et al. Ankle fractures in patients with diabetes mellitus. J Bone Joint Surg [Br] 2005;87-B:489-95.
62. Costigan W, Thordarson DB, Debnath UK. Operative management of ankle fractures in patients with diabetes mellitus. Foot Ankle Int 2007;28:32-7.
63. Ayoub MA. Ankle fractures in diabetic neuropathic arthroplasty: can tibiotalar arthrodesis salvage the limb? J Bone Joint Surg [Br] 2008;90-B:906-14.